Surgery Partners (NASDAQ:SGRY) Shares Up 3.6%

Surgery Partners, Inc. (NASDAQ:SGRY) shares shot up 3.6% during mid-day trading on Tuesday . The company traded as high as $23.93 and last traded at $23.92. 144,889 shares were traded during trading, a decline of 84% from the average session volume of 922,019 shares. The stock had previously closed at $23.08.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on SGRY. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 target price on shares of Surgery Partners in a research report on Tuesday. Citigroup decreased their price target on Surgery Partners from $42.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a report on Wednesday, May 1st. StockNews.com upgraded Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Finally, Macquarie started coverage on Surgery Partners in a report on Friday, June 28th. They issued an “outperform” rating and a $31.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $41.38.

Surgery Partners Stock Performance

The company has a 50 day moving average price of $25.26 and a 200 day moving average price of $28.33. The company has a market capitalization of $3.25 billion, a PE ratio of 26.84, a PEG ratio of 1.75 and a beta of 2.78. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.02. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The firm had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. Equities analysts forecast that Surgery Partners, Inc. will post 0.88 EPS for the current year.

Insider Buying and Selling

In related news, insider Danielle Burkhalter sold 6,000 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total transaction of $158,340.00. Following the transaction, the insider now directly owns 30,354 shares in the company, valued at $801,042.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Surgery Partners

Several large investors have recently added to or reduced their stakes in the stock. Wesbanco Bank Inc. increased its position in Surgery Partners by 53.4% in the second quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company’s stock worth $936,000 after buying an additional 13,700 shares during the period. DekaBank Deutsche Girozentrale increased its position in Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after buying an additional 1,375 shares during the period. Janus Henderson Group PLC increased its position in Surgery Partners by 7,987.1% in the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after buying an additional 2,473,282 shares during the period. Bamco Inc. NY increased its position in Surgery Partners by 100.0% in the first quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock worth $2,685,000 after buying an additional 45,000 shares during the period. Finally, Magnetar Financial LLC increased its position in Surgery Partners by 511.7% in the first quarter. Magnetar Financial LLC now owns 165,466 shares of the company’s stock worth $4,936,000 after buying an additional 138,415 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.